Automating Drug Discovery
Infographic Sep 17, 2019 | By Laura Elizabeth Lansdowne, Science Writer, Technology Networks
Over recent years, the number of newly approved drugs brought to market has continued to decrease. Many drugs fail due to the fact they do not show efficacy at specific stages of the drug development pipeline, typically Phase II or Phase III.
Subsequently, the pharmaceutical industry is facing pressures to optimize the drug discovery phase of the drug development pipeline, to avoid late-stage failures, and streamline the process.
One approach to doing this is by adopting automation.
Download this infographic to learn about:
- The benefits of an automated drug discovery laboratory
- Microfluidics and lab-on-a-chip technologies
- Machine learning and AI
- Liquid handling robotics
Biotherapeutics now represent a rapidly growing portion of the pharmaceutical market. Download this infographic to learn more about what biotherapeutics are, why it is important to characterize and analyze them and four key approaches for biotherapeutic characterization and analysis.READ MORE
The aim of personalized medicine is to a move away from the traditional “one size fits all” approach to the treatment of diseases – such as cancer. For patients where standard clinical options have been exhausted, novel personalized therapeutics may be required. Patient-derived cancer models, such as “organoids”, can help predict an individual’s response to a drug – both efficacy and toxicity – prior to administration.READ MORE
Both inductively coupled plasma optical emission spectroscopy (ICP-OES) and inductively coupled plasma mass spectrometry (ICP-MS) are analytical techniques important for the analysis of trace elements in a host of mediums. Download this infographic to learn more about these techniques and their uses.READ MORE